Basil Al-Sabeq1, Faisal Nabi, Dipan J Shah. 1. Division of Cardiovascular Imaging, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.
Abstract
PURPOSE OF REVIEW: Left ventricular systolic dysfunction because of coronary artery disease is common, and ascertaining which patients will benefit from revascularization can be challenging. Viability testing is an accepted means by which to base this decision, with multiple noninvasive imaging modalities available for this purpose. This review aims to highlight the key role of cardiac magnetic resonance in myocardial viability assessment, with a focus on its unique strengths over other imaging modalities. RECENT FINDINGS: Transmural extent of hyperenhancement with late gadolinium imaging has been shown to be greater acutely in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention and regress at follow-up studies. An explanation for this reported phenomenon and an argument against redefining CMR viability criteria in the acute setting will be offered. SUMMARY: Although not universally available, cardiac magnetic resonance is an exceptionally powerful and well tolerated imaging modality that should be considered when viability testing will influence patient management. Although observational outcomes data suggest a promising prognostic role for viability, randomized studies in this area are needed.
PURPOSE OF REVIEW: Left ventricular systolic dysfunction because of coronary artery disease is common, and ascertaining which patients will benefit from revascularization can be challenging. Viability testing is an accepted means by which to base this decision, with multiple noninvasive imaging modalities available for this purpose. This review aims to highlight the key role of cardiac magnetic resonance in myocardial viability assessment, with a focus on its unique strengths over other imaging modalities. RECENT FINDINGS: Transmural extent of hyperenhancement with late gadolinium imaging has been shown to be greater acutely in ST elevation myocardial infarctionpatients undergoing primary percutaneous coronary intervention and regress at follow-up studies. An explanation for this reported phenomenon and an argument against redefining CMR viability criteria in the acute setting will be offered. SUMMARY: Although not universally available, cardiac magnetic resonance is an exceptionally powerful and well tolerated imaging modality that should be considered when viability testing will influence patient management. Although observational outcomes data suggest a promising prognostic role for viability, randomized studies in this area are needed.
Authors: Ana Luiza Mansur Souto; Rafael Mansur Souto; Isabella Cristina Resende Teixeira; Marcelo Souto Nacif Journal: Arq Bras Cardiol Date: 2017-05 Impact factor: 2.000
Authors: Anja Wagner; Heiko Mahrholdt; Thomas A Holly; Michael D Elliott; Matthias Regenfus; Michele Parker; Francis J Klocke; Robert O Bonow; Raymond J Kim; Robert M Judd Journal: Lancet Date: 2003-02-01 Impact factor: 79.321
Authors: Joseph B Selvanayagam; Attila Kardos; Jane M Francis; Frank Wiesmann; Steffen E Petersen; David P Taggart; Stefan Neubauer Journal: Circulation Date: 2004-09-07 Impact factor: 29.690
Authors: R Hoffmann; H Lethen; T Marwick; M Arnese; P Fioretti; A Pingitore; E Picano; T Buck; R Erbel; F A Flachskampf; P Hanrath Journal: J Am Coll Cardiol Date: 1996-02 Impact factor: 24.094
Authors: Michael E Farkouh; Michael Domanski; Lynn A Sleeper; Flora S Siami; George Dangas; Michael Mack; May Yang; David J Cohen; Yves Rosenberg; Scott D Solomon; Akshay S Desai; Bernard J Gersh; Elizabeth A Magnuson; Alexandra Lansky; Robin Boineau; Jesse Weinberger; Krishnan Ramanathan; J Eduardo Sousa; Jamie Rankin; Balram Bhargava; John Buse; Whady Hueb; Craig R Smith; Victoria Muratov; Sameer Bansilal; Spencer King; Michel Bertrand; Valentin Fuster Journal: N Engl J Med Date: 2012-11-04 Impact factor: 91.245
Authors: Borja Ibanez; Stefan James; Stefan Agewall; Manuel J Antunes; Chiara Bucciarelli-Ducci; Héctor Bueno; Alida L P Caforio; Filippo Crea; John A Goudevenos; Sigrun Halvorsen; Gerhard Hindricks; Adnan Kastrati; Mattie J Lenzen; Eva Prescott; Marco Roffi; Marco Valgimigli; Christoph Varenhorst; Pascal Vranckx; Petr Widimský Journal: Eur Heart J Date: 2018-01-07 Impact factor: 29.983
Authors: Heerajnarain Bulluck; Stefania Rosmini; Amna Abdel-Gadir; Anish N Bhuva; Thomas A Treibel; Marianna Fontana; Daniel S Knight; Sabrina Nordin; Alex Sirker; Anna S Herrey; Charlotte Manisty; James C Moon; Derek J Hausenloy Journal: Sci Rep Date: 2017-11-07 Impact factor: 4.379
Authors: Joëlle Elias; Ivo M van Dongen; Loes P Hoebers; Dagmar M Ouweneel; Bimmer E P M Claessen; Truls Råmunddal; Peep Laanmets; Erlend Eriksen; René J van der Schaaf; Dan Ioanes; Robin Nijveldt; Jan G Tijssen; Alexander Hirsch; José P S Henriques Journal: J Cardiovasc Magn Reson Date: 2017-07-19 Impact factor: 5.364